TY  - GEN
AU  - Smith II,John W
AU  - Kurt,Robert A
AU  - Baher,Angelo G
AU  - Denman,Susan
AU  - Justice,Lisa
AU  - Doran,Teri
AU  - Gilbert,Mark
AU  - Alvord,W Gregory
AU  - Urba,Walter J
TI  - Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma
SN  - 1524-9557
PY  - 2003///0926
KW  - Aged
KW  - Carcinoma, Renal Cell
KW  - immunology
KW  - Combined Modality Therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - administration & dosage
KW  - Humans
KW  - Immunotherapy
KW  - methods
KW  - Injections, Intravenous
KW  - Injections, Subcutaneous
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Melanoma
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Reference Values
KW  - Risk Assessment
KW  - Skin Neoplasms
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1097/00002371-200303000-00005
ER  -